Перейти к основному содержанию
AkademIndex

Продукты

Для разработчиков

AkademBaseОткрытый API экосистемы
Обзорная статья

Development of Graphene-Based Materials with the Targeted Action for Cancer Theranostics

Konstantin N. SemenovGranov Russian Research Centre for Radiology and Surgical Technologies, Saint Petersburg, 197758, RussiaOlga S. ShemchukPavlov First Saint Petersburg State Medical University, Saint Petersburg, 197022, RussiaSergei V. AgeevPavlov First Saint Petersburg State Medical University, Saint Petersburg, 197022, RussiaPavel A. AndoskinPavlov First Saint Petersburg State Medical University, Saint Petersburg, 197022, RussiaGleb O. IurevPavlov First Saint Petersburg State Medical University, Saint Petersburg, 197022, RussiaI. V. MurinSaint Petersburg State University, Saint Petersburg, 199034, RussiaPavel K KozhukhovSaint Petersburg State University, Saint Petersburg, 199034, RussiaD. N. MaystrenkoGranov Russian Research Centre for Radiology and Surgical Technologies, Saint Petersburg, 197758, RussiaO. MolchanovGranov Russian Research Centre for Radiology and Surgical Technologies, Saint Petersburg, 197758, RussiaDilafruz K. KholmurodovaSamarkand Medical University, Samarkand, 100400, UzbekistanJasur A RizaevSamarkand Medical University, Samarkand, 100400, UzbekistanVladimir V. SharoykoGranov Russian Research Centre for Radiology and Surgical Technologies, Saint Petersburg, 197758, Russia
Biochemistry (Moscow)journal2024en
ABI

Аннотация

The review summarises the prospects in the application of graphene and graphene-based nanomaterials (GBNs) in nanomedicine, including drug delivery, photothermal and photodynamic therapy, and theranostics in cancer treatment. The application of GBNs in various areas of science and medicine is due to the unique properties of graphene allowing the development of novel ground-breaking biomedical applications. The review describes current approaches to the production of new targeting graphene-based biomedical agents for the chemotherapy, photothermal therapy, and photodynamic therapy of tumors. Analysis of publications and FDA databases showed that despite numerous clinical studies of graphene-based materials conducted worldwide, there is a lack of information on the clinical trials on the use of graphene-based conjugates for the targeted drug delivery and diagnostics. The review will be helpful for researchers working in development of carbon nanostructures, material science, medicinal chemistry, and nanobiomedicine.

Перевод пока недоступен

Темы

Идентификаторы

Цитирования и источники